Comparing Biktarvy vs Genvoya
| Biktarvy (bictegravir / emtricitabine / tenofovir alafenamide) | Genvoya (cobicistat / elvitegravir / emtricitabine / tenofovir alafenamide) |
|
|---|
| Biktarvy (bictegravir / emtricitabine / tenofovir alafenamide) | Genvoya (cobicistat / elvitegravir / emtricitabine / tenofovir alafenamide) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Biktarvy is a combination tablet that contains three antiviral agents which may be used to treat HIV-1 in adults and children weighing more than 25kg (55lb). It is generally well-tolerated and the... View more |
Prescription only
Genvoya is a combination antiviral medication that also includes a pharmacokinetic enhancer that can be used to treat people and children with HIV-1 who meet certain criteria. It is 84% to 93%... View more |
Related suggestions Popular comparisons
|
|||||||||||||||
| More about Biktarvy (bictegravir / emtricitabine / tenofovir alafenamide) | More about Genvoya (cobicistat / elvitegravir / emtricitabine / tenofovir alafenamide) | ||||||||||||||||
| Ratings & Reviews | |||||||||||||||||
|
Biktarvy has an average rating of 7.2 out of 10 from a total of 213 ratings on Drugs.com. 58% of reviewers reported a positive effect, while 20% reported a negative effect. |
Genvoya has an average rating of 7.3 out of 10 from a total of 129 ratings on Drugs.com. 61% of reviewers reported a positive effect, while 19% reported a negative effect. |
||||||||||||||||
| Drug Class | |||||||||||||||||
| Side Effects | |||||||||||||||||
| Generic Availability | |||||||||||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Biktarvy prices |
View all Genvoya prices |
||||||||||||||||
| Dosage Forms Available | |||||||||||||||||
|
|
||||||||||||||||
| Brand Names | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | |||||||||||||||||
|
180 hours |
17 hours |
||||||||||||||||
| CSA Schedule ** View glossary of terms | |||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | |||||||||||||||||
|
Summary unavailable. See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | |||||||||||||||||
|
A total of 433 drugs are known to interact with Biktarvy:
|
A total of 688 drugs are known to interact with Genvoya:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
||||||||||||||||
| Disease Interactions | |||||||||||||||||
| First Approval Date | |||||||||||||||||
|
February 07, 2018 |
N/A |
||||||||||||||||
| WADA Class View World Anti-Doping Agency classifications. | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| More Information | |||||||||||||||||
| Patient resources | |||||||||||||||||
| Professional Resources | |||||||||||||||||
| Related Treatment Guide | |||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.